💨 Abstract

Researchers from Tata Memorial Centre and National Institute of Biomedical Genomics have identified key genomic factors contributing to breast cancer hormone treatment resistance. These factors include mutation in three key genes, DNA repair deficiency, and shortened telomeres. The study aims to develop targeted treatments for breast cancer in the local context. The research was funded by the Department of Biotechnology and suggests the importance of investing in fundamental cancer research for precision medicine in India.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖